ALX Oncology

$41.76
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.76 (+1.85%) Today
$0.00 (0.00%) As of 4:03 PM EDT after-hours

Why Robinhood?

You can buy or sell ALX Oncology and other stocks, options, and ETFs commission-free!

About ALXO

ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. Read More The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia on April 1, 2020 and is headquartered in Burlingame, CA. The listed name for ALXO is ALX Oncology Holdings Inc. Common Stock.

Employees
Headquarters
Burlingame, California
Founded
Market Cap
1.54B
Price-Earnings Ratio
Dividend Yield
Average Volume
160.26K
High Today
$42.37
Low Today
$40.76
Open Price
$42.00
Volume
53.03K
52 Week High
$52.00
52 Week Low
$28.01

Collections

ALXO Earnings

-$0.33
-$0.22
-$0.11
$0.00
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 16, After Hours

You May Also Like